Safety and Efficacy of CIS43LS Anti-malaria mAb in Mali

NCT04329104 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

348

Enrollment

NIH

Sponsor class

Conditions

Plasmodium Falciparum Infection
Malaria

Interventions

BIOLOGICAL: VRC-MALMAB0100-00-AB (CIS43LS)
OTHER: Normal saline

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]
[object Object]